Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LIPE | Q05469 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL19371425 | 0.98 | CA12 (0.42) | CA12CA1CA2CA9LMNA | |
| SCHEMBL3076681 | 0.85 | — | — | |
| SCHEMBL28803313 | 0.85 | — | — | |
| SCHEMBL4981455 | 0.83 | CA12 (0.56) | CA12CA1CA2CA9LMNA | |
| Hydrochloric Acid SCHEMBL27505323 | 0.81 | CA12 (0.54) | CA12CA1CA2CA9LMNA | |
| SCHEMBL28170308 | 0.81 | F2 (0.36) | — | |
| Hydrochloric Acid SCHEMBL22372381 | 0.79 | F2 (0.34) | — | |
| SCHEMBL2947032 | 0.79 | CA12 (0.47) | CA12CA1CA2CA9LMNA | |
| SCHEMBL28170293 | 0.78 | GNAI3 (0.34) | — | |
| Hydrochloric Acid SCHEMBL22372399 | 0.78 | F2 (0.38) | LMNAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200277255-A1 | BIGUANIDE COMPOUND AND USE THEREOF | IMMUNOMET THERAPEUTICS INC. | 2020-09-03 | — | — | US | claimed |
| US-10626085-B2 | Biguanide compound and use thereof | IMMUNOMET THERAPEUTICS INC. (US) | 2020-04-21 | — | — | US | claimed |
| US-20180044283-A1 | BIGUANIDE COMPOUND AND USE THEREOF | IMMUNOMET THERAPEUTICS INC. (US) | 2018-02-15 | — | — | US | claimed |
| EP-3222614-A2 | BIGUANIDE COMPOUND AND USE THEREOF | Immunomet Therapeutics Inc. (US) | 2017-09-27 | — | — | EP | claimed |
| CN-100335427-C | Oxygen scavenger and boiler water treatment chemical | KURITA KOGYO K K (JP) | 2007-09-05 | — | — | CN | claimed |
| US-6861032-B2 | Adding to boiler water an oxygen scavenger including, as an effective component, a heterocyclic compound with N-substituted amino group, or the salt thereof, and alkaline agent and/or water soluble polymer | KURITA WATER INDUSTRIES LTD. (JP) | 2005-03-01 | — | — | US | claimed |
| CN-1557747-A | Oxygen scavenger and boiler water treatment chemical | ���﹤ҵ��ʽ���� | 2004-12-29 | — | — | CN | claimed |
| US-20030141483-A1 | Adding to boiler water an oxygen scavenger including, as an effective component, a heterocyclic compound with N-substituted amino group, or the salt thereof, and alkaline agent and/or water soluble polymer | SHIMURA YUKIMASA (JP) | 2003-07-31 | — | — | US | claimed |
| US-6540923-B2 | For adding to boiler feed water; useful in inhibiting the corrosion in a boiler system by removing dissolved oxygen | KURITA WATER INDUSTRIES LTD. (JP) | 2003-04-01 | — | — | US | claimed |
| CN-1389411-A | Oxygen scavenger and boiler water treatment chemical | KURITA KOGYO K K (JP) | 2003-01-08 | — | — | CN | claimed |
| US-20020100896-A1 | For adding to boiler feed water; useful in inhibiting the corrosion in a boiler system by removing dissolved oxygen | KURITA WATER INDUSTRIES LTD. | 2002-08-01 | — | — | US | claimed |
| US-20020046976-A1 | Heterocyclic compound with N-substituted amino group or its salt, and an alkaline agent and/or water soluble polymer | SHIMURA YUKIMASA (JP) | 2002-04-25 | — | — | US | claimed |
| US-6346206-B1 | CHEMICAL COMPRISING HETEROCYCLIC COMPOUND SELECTED FROM 1-AMINOPYRROLIDINE, 1,4-DIAMINOPIPERAZINE, 1-AMINOPIPERIDINE, 1-AMINOHOMOPIPERIDINE, MORPHOLINOBIGUANIDE AND WATER SOLUBLE SALTS THEREOF, AND NEUTRAL AMINE | KURITA WATER INDUSTRIES LTD. (JP) | 2002-02-12 | — | — | US | claimed |
| CN-1187471-A | Oxygen scavenger and boiler water treatment chemical | KURITA WATER IND LTD (JP) | 1998-07-15 | — | — | CN | claimed |
| EP-0845438-A1 | Oxygen scavenger and boiler water treatment chemical | KURITA WATER INDUSTRIES LTD. (JP) | 1998-06-03 | — | — | EP | claimed |
| EP-4692247-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260022211-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-01-22 | — | — | US | disclosed |
| US-5989440-A | DEOXYGENATION OF BOILER WATER WITH AN AMINO SUBSTITUTED NITROGEN HETEROCYCLE COMPOUND OR WATER SOLUBLE ORGANIC SALT THEREOF TO INHIBIT BY-PRODUCT FORMATION AND BOILER CORROSION | KURITA WATER INDUSTRIES LTD. (JP) | 1999-11-23 | — | — | US | disclosed |
| CN-1187471-A | Oxygen scavenger and boiler water treatment chemical | KURITA WATER IND LTD (JP) | 1998-07-15 | — | — | CN | disclosed |
| EP-0845438-A1 | Oxygen scavenger and boiler water treatment chemical | KURITA WATER INDUSTRIES LTD. (JP) | 1998-06-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10626085-B2 | Biguanide compound and use thereof | MKI67, GCG, GCKR | CA12 2765/4885CA1 2719/4885CA2 2929/4885 |
| US-20180044283-A1 | BIGUANIDE COMPOUND AND USE THEREOF | MKI67, GCG, GCKR | CA12 2765/4885CA1 2719/4885CA2 2929/4885 |
| US-20260022211-A1 | CURABLE COMPOSITION | H1-4, H1-0, H1-2 | CA12 710/4885CA1 405/4885CA2 1656/4885 |
| US-20200277255-A1 | BIGUANIDE COMPOUND AND USE THEREOF | MKI67, GCG, GCKR | CA12 2765/4885CA1 2719/4885CA2 2929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.